Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing-Reference-Cited by-同舟云学术

Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing

Published:2017-03 Issue:3 Volume:1863 Page:721-730
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

van Kuilenburg André B.P.,Meijer Judith,Maurer Dirk,Dobritzsch Doreen,Meinsma Rutger,Los Maartje,Knegt Lia C.,Zoetekouw Lida,Jansen Rob L.H.,Dezentjé Vincent,van Huis-Tanja Lieke H.,van Kampen Roel J.W.,Hertz Jens Michael,Hennekam Raoul C.M.

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference50 articles.

1. Systemic therapy for colorectal cancer;Meyerhardt;N. Engl. J. Med.,2005

2. Capecitabine as adjuvant treatment for stage III colon cancer;Twelves;N. Engl. J. Med.,2005

3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J. Clin. Oncol.,2009

4. Adjuvant treatment of colon cancer: what is next?;Van Loon;Curr. Opin. Oncol.,2011

5. Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil;Johnson;Adv. Enzym. Regul.,2001

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders;Genetics in Medicine;2024-06

2. Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants;JCO Precision Oncology;2024-05

3. Fluoropyrimidine Toxicity: the Hidden Secrets of DPYD;Current Drug Metabolism;2024-02

4. Clinical Implementation of Rare and Novel DPYD Variants for Personalizing Fluoropyrimidine Treatment: Challenges and Opportunities;International Journal of Biological Sciences;2024

5. Precision medicine and drug safety;Comprehensive Precision Medicine;2024